drugset / Trial / NCT00223236

Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence

NCT00223236

Phase 3 Completed 44 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this research is to determine if a citicoline supplement is associated with a reduction in cocaine use and craving in patients with bipolar disorder (a mental disorder marked by alternating periods of mania and depression) or schizoaffective disorder/bipolar type (a psychotic disturbance in which there is a mixture of schizophrenic and manic-depressive symptoms) and cocaine abuse/dependence. This research also wants to explore if citicoline supplements are associated with greater improvement in symptoms of mania and on memory and cognition (the mental faculty of perception, reasoning, and judgement) in these patients.

Timeline

Start
2010-07
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citicoline Other / unclassified 2000 mg